Stryker Corporation (SYK)

Accelerated hospital capital equipment spending, record Mako robotic placements in hospital and ASC settings, and rapid clearance of Peripheral Vascular backorders drive double-digit earnings compounding and accelerated operating margin expansion ahead of house expectations.

• EPS annual compound growth of 12.5% through explicit forecast horizon.
• Adjusted operating margin expands beyond 21.2% ahead of schedule.
• Rapid ASC robotic placement acceleration and sustained procedure volume expansion.